PRESS RELEASE published on 10/17/2023 at 17:45, 2 years 1 month ago BROADPEAK SA: 2023 first-half results
PRESS RELEASE published on 09/27/2023 at 17:45, 2 years 2 months ago BROADPEAK SA: Broadpeak’s Multicast ABR offer chosen by Orange in Spain
PRESS RELEASE published on 07/25/2023 at 17:58, 2 years 4 months ago BROADPEAK SA: Broadpeak publishes first-half 2023 revenue
PRESS RELEASE published on 05/16/2023 at 18:11, 2 years 6 months ago BROADPEAK SA: Publication by Broadpeak of its 2023 first-quarter revenue
PRESS RELEASE published on 04/27/2023 at 18:00, 2 years 7 months ago BROADPEAK SA: Broadpeak publishes its annual results
PRESS RELEASE published on 04/06/2023 at 18:00, 2 years 7 months ago BROADPEAK SA: Broadpeak is launching a new CDN solution offering unparalleled technological and ecological performance
PRESS RELEASE published on 03/01/2023 at 17:46, 2 years 9 months ago BROADPEAK SA: Broadpeak reports annual revenue
PRESS RELEASE published on 01/18/2023 at 18:00, 2 years 10 months ago BROADPEAK SA: One year after launch, a SaaS offering that keeps its promises
Published on 12/05/2025 at 02:35, 3 hours 28 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 3 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 58 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 3 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 33 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 12 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 38 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 48 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 52 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 3 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 18 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 19 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 2 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
